,  том 64 ,  издание 13 ,  страницы 1447-1458

Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapy

Тип публикации: Journal Article
Дата публикации: 2012-10-01
SCImago Q1
Tоп 10% SCImago
WOS Q1
БС1
SJR: 4.015
CiteScore: 39
Impact factor: 21
ISSN: 0169409X, 18728294
Pharmaceutical Science
Краткое описание
Theragnostic nanoparticles (NPs) contain diagnostic and therapeutic functions in one integrated system, enabling diagnosis, therapy, and monitoring of therapeutic response at the same time. For diagnostic function, theragnostic NPs require the inclusion of noninvasive imaging modalities. Among them, optical imaging has various advantages including sensitivity, real-time and convenient use, and non-ionization safety, which make it the leading technique for theragnostic NPs. For therapeutic function, theragnostic NPs have been applied to chemotherapy, photodynamic therapy, siRNA therapy and photothermal therapy. In this review, we present a recent progress reported in the development and applications of theragnostic NPs for cancer therapy. More specifically, we will focus on theragnostic NPs related with optical imaging, highlighting promising strategies based on optical imaging techniques.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Топ-30

Журналы

1
2
3
4
5
6
7
8
Biomaterials
8 публикаций, 3.83%
Journal of Controlled Release
7 публикаций, 3.35%
Molecular Pharmaceutics
5 публикаций, 2.39%
Nanomaterials
4 публикации, 1.91%
Coordination Chemistry Reviews
4 публикации, 1.91%
Journal of Nanobiotechnology
3 публикации, 1.44%
International Journal of Molecular Sciences
3 публикации, 1.44%
Advanced Drug Delivery Reviews
3 публикации, 1.44%
International Journal of Pharmaceutics
3 публикации, 1.44%
Advanced Functional Materials
3 публикации, 1.44%
Small
3 публикации, 1.44%
Langmuir
3 публикации, 1.44%
Journal of Materials Chemistry B
3 публикации, 1.44%
Biomaterials Science
3 публикации, 1.44%
Expert Opinion on Drug Delivery
3 публикации, 1.44%
Pharmaceutics
3 публикации, 1.44%
Materials
2 публикации, 0.96%
Cancers
2 публикации, 0.96%
Seminars in Cancer Biology
2 публикации, 0.96%
Cancer Letters
2 публикации, 0.96%
Nanomedicine: Nanotechnology, Biology, and Medicine
2 публикации, 0.96%
Colloids and Surfaces B: Biointerfaces
2 публикации, 0.96%
Journal of Drug Delivery Science and Technology
2 публикации, 0.96%
Chemistry - A European Journal
2 публикации, 0.96%
Advanced healthcare materials
2 публикации, 0.96%
Particle and Particle Systems Characterization
2 публикации, 0.96%
Advanced Materials
2 публикации, 0.96%
Biomacromolecules
2 публикации, 0.96%
Analytical Chemistry
2 публикации, 0.96%
1
2
3
4
5
6
7
8

Издатели

10
20
30
40
50
60
70
Elsevier
66 публикаций, 31.58%
Wiley
27 публикаций, 12.92%
American Chemical Society (ACS)
25 публикаций, 11.96%
Springer Nature
23 публикации, 11%
MDPI
19 публикаций, 9.09%
Royal Society of Chemistry (RSC)
15 публикаций, 7.18%
Taylor & Francis
7 публикаций, 3.35%
Frontiers Media S.A.
4 публикации, 1.91%
Bentham Science Publishers Ltd.
2 публикации, 0.96%
Hindawi Limited
2 публикации, 0.96%
Oxford University Press
1 публикация, 0.48%
Spandidos Publications
1 публикация, 0.48%
World Scientific
1 публикация, 0.48%
Pharmaceutical Society of Korea
1 публикация, 0.48%
Polymer Society of Korea
1 публикация, 0.48%
Higher Education Press
1 публикация, 0.48%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 0.48%
Neoplasia Press
1 публикация, 0.48%
SAGE
1 публикация, 0.48%
IntechOpen
1 публикация, 0.48%
AME Publishing Company
1 публикация, 0.48%
Scientific Scholar
1 публикация, 0.48%
OAE Publishing Inc.
1 публикация, 0.48%
10
20
30
40
50
60
70
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
 Войти с ORCID
Метрики
209
Поделиться
Цитировать
ГОСТ |
Цитировать
Ryu J. S. et al. Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapy // Advanced Drug Delivery Reviews. 2012. Vol. 64. No. 13. pp. 1447-1458.
ГОСТ со всеми авторами (до 50) Скопировать
Ryu J. S., Koo H., Sun I. O., Yuk S. H., Choi K., Kim K., Kwon I. C. Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapy // Advanced Drug Delivery Reviews. 2012. Vol. 64. No. 13. pp. 1447-1458.
RIS |
Цитировать
TY - JOUR
DO - 10.1016/j.addr.2012.06.012
UR - https://doi.org/10.1016/j.addr.2012.06.012
TI - Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapy
T2 - Advanced Drug Delivery Reviews
AU - Ryu, Ju Seok
AU - Koo, Heebeom
AU - Sun, In O
AU - Yuk, Soon Hong
AU - Choi, Kuiwon
AU - Kim, Kwangmeyung
AU - Kwon, Ick Chan
PY - 2012
DA - 2012/10/01
PB - Elsevier
SP - 1447-1458
IS - 13
VL - 64
PMID - 22772034
SN - 0169-409X
SN - 1872-8294
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2012_Ryu,
author = {Ju Seok Ryu and Heebeom Koo and In O Sun and Soon Hong Yuk and Kuiwon Choi and Kwangmeyung Kim and Ick Chan Kwon},
title = {Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapy},
journal = {Advanced Drug Delivery Reviews},
year = {2012},
volume = {64},
publisher = {Elsevier},
month = {oct},
url = {https://doi.org/10.1016/j.addr.2012.06.012},
number = {13},
pages = {1447--1458},
doi = {10.1016/j.addr.2012.06.012}
}
MLA
Цитировать
Ryu, Ju Seok, et al. “Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapy.” Advanced Drug Delivery Reviews, vol. 64, no. 13, Oct. 2012, pp. 1447-1458. https://doi.org/10.1016/j.addr.2012.06.012.
Ошибка в публикации?